Sarcopenia Pipeline
Jul 28, 2025
Therapeutic Innovation in Sarcopenia Treatment: From TNF-alpha Inhibitors to GLP-1 Agonists
Sarcopenia, often dubbed the “silent muscle thief,” is a progressive loss of skeletal muscle mass and strength that typically begins after the age of 30, accelerating after 60. Affecting up to 50% of adults over 80, sarcopenia isn’t just about frailty—it’s linked to increased risks of falls, fractures, loss of inde...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
